Phase 2Status unknownAge-related condition
A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
Parkinson Associated Risk Factor Study (PARS): Evaluating Potential Screening Tools for Parkinson Disease
- Sponsor
- Institute for Neurodegenerative Disorders (Academic or other)
- Enrollment
- 3,000 planned
- Conditions
- Parkinson Disease
- Interventions
- [123I]β-CIT and SPECT imaging; [123I]β-CIT
- Ages
- adults, older adults
- Registry
- NCT00387075
Full record on ClinicalTrials.gov
From the registry
This study is designed as a prospective cohort study to test the strategy of combining two biomarkers of parkinsonism, olfaction and brain imaging with a radioactively labeled drug, \[123I\]β-CIT , in a population of first-degree relatives of PD patients as a tool to establish an 'at risk' Parkinson disease cohort without motor symptoms of PD. First-degree relatives of PD will be recruited through PD research sites and national foundations to participate in this study. In addition, first degree relatives of PD patients will be recruited directly through advertising.
Primary outcomes
- the mean striatal uptake of [123I]B-CIT in first-degree relatives with a loss of odor identification, compared to an established healthy control database (age 40-70; n=50)
History
Primary completion
Last registry update
Started
Registered